|
1
|
Konstantinides SV, Torbicki A, Agnelli G,
Danchin N, Fitzmaurice D, Galiè N, Gibbs JSR, Huisman MV, Humbert
M, Kucher N, et al: 2014 ESC guidelines on the diagnosis and
management of acute pulmonary embolism. The task force for the
diagnosis and management of acute pulmonary embolism of the
european society of cardiology (ESC). Endorsed by the European
respiratory society (ERS). Eur Heart J. 35:3033–3080. 2014.
|
|
2
|
Go AS, Mozaffarian D, Roger VL, Benjamin
EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al:
Heart disease and stroke statistics-2014 update: A report from the
American heart association. Circulation. 129:e28–e292.
2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Timp JF, Braekkan SK, Versteeg HH and
Cannegieter SC: Epidemiology of cancer-associated venous
thrombosis. Blood. 122:1712–1723. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cronin-Fenton DP, Søndergaard F, Pedersen
LA, Fryzek JP, Cetin K, Acquavella J, Baron JA and Sørensen HT:
Hospitalisation for venous thromboembolism in cancer patients and
the general population: A population-based cohort study in Denmark,
1997-2006. Br J Cancer. 103:947–953. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Madison CJ, Melson RA, Conlin MJ, Gundle
KR, Thompson RF and Calverley DC: Thromboembolic risk in patients
with lung cancer receiving systemic therapy. Br J Haematol.
194:179–190. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Patel JN, Jiang C, Hertz DL, Mulkey FA,
Owzar K, Halabi S, Ratain MJ, Friedman PN, Small EJ, Carducci MA,
et al: Bevacizumab and the risk of arterial and venous
thromboembolism in patients with metastatic, castration-resistant
prostate cancer treated on cancer and leukemia group B (CALGB)
90401 (alliance). Cancer. 121:1025–1031. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Heit JA, Silverstein MD, Mohr DN,
Petterson TM, O'Fallon WM and Melton LJ III: Predictors of survival
after deep vein thrombosis and pulmonary embolism: A
population-based, cohort study. Arch Intern Med. 159:445–453.
1999.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kostrubiec M, Pruszczyk P, Bochowicz A,
Pacho R, Szulc M, Kaczynska A, Styczynski G, Kuch-Wocial A,
Abramczyk P, Bartoszewicz Z, et al: Biomarker-based risk assessment
model in acute pulmonary embolism. Eur Heart J. 26:2166–2172.
2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Dalen JE: Pulmonary embolism: What have we
learned since Virchow? Natural history, pathophysiology, and
diagnosis. Chest. 122:1440–1456. 2002.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Keron C: Natural history of venous
thromboembolism. Circulation. 107 (23 Suppl 1):S122–S130.
2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Cushman M, Tsai AW, White RH, Heckbert SR,
Rosamond WD, Enright P and Folsom AR: Deep vein thrombosis and
pulmonary embolism in two cohorts: The longitudinal investigation
of thromboembolism etiology. Am J Med. 117:19–25. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Drăgan A and Drăgan AŞ: Novel insights in
venous thromboembolism risk assessment methods in ambulatory cancer
patients: From the guidelines to clinical practice. Cancers
(Basel). 16(458)2024.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Goldhaber SZ: Pulmonary embolism. In:
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.
9th edition. Philadelphia, pp1679-1695, 2012.
|
|
14
|
Khorana AA, Kuderer NM, Culakova E, Lyman
GH and Francis CW: Development and validation of a predictive model
for chemotherapy-associated thrombosis. Blood. 111:4902–4907.
2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Moik F, Makatsariya A and Cihan Ay:
Challenging anticoagulation cases: Cancer-associated venous
thromboembolism and chemotherapy-induced thrombocytopenia-A
case-based review of clinical management. Thromb Res. 199:38–42.
2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Willems RAL, Michiels N, Lanting VR,
Bouwense S, van den Broek BLJ, Graus M, Klok FA, Koerkamp BG, de
Laat B, Roest M, et al: Venous thromboembolism and primary
thromboprophylaxis in perioperative pancreatic cancer care. Cancers
(Basel). 15(3546)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kapteijn MY, Zwaan S, Ter Linden E,
Laghmani EH, van den Akker RFP, Rondon AMR, van der Zanden SY,
Neefjes J, Versteeg HH and Buijs JT: Temozolomide and lomustine
induce tissue factor expression and procoagulant activity in
glioblastoma cells in vitro. Cancers (Basel).
15(2347)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Roberts R, Borley A, Hanna A, Dolan G,
Ganesh S and Williams EM: Identifying risk factors for
anthracycline chemotherapy-induced phlebitis in women with breast
cancer: An observational study. Clin Oncol (R Coll Radiol).
33:230–240. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Naito M, Torii R, Hashimoto Y, Kawamoto Y,
Hayashi K, Shinoda H, Honjo Y and Hiroyoshi M: Increase in
carbohydrate antigen 19-9 levels without tumor progression after
polaprezinc administration that induced deep vein thrombosis in a
colon cancer patient. Chemotherapy. 64:163–166. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Muhsin-Sharafaldine MR and McLellan AD:
Apoptotic vesicles: Deathly players in cancer-associated
coagulation. Immunol Cell Biol. 96:723–732. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Setiawan B, Permatadewi CO, de Samakto B,
Bugis A, Naibaho RM, Pangarsa EA, Santosa D and Suharti C: Von
Willebrand factor: Antigen and ADAMTS-13 level, but not soluble
P-selectin, are risk factors for the first asymptomatic deep vein
thrombosis in cancer patients undergoing chemotherapy. Thromb J.
18(33)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Setiawan B, Manurung AKW, Zulizar AA,
Budianto W, Sukarnowati TW, Pangarsa EA, Santosa D, Setiabudy RD
and Suharti C: Changes in plasma levels of IL-6 and D-dimer in
high-risk thrombosis cancer patients undergoing chemotherapy. Bali
Med J. 11:520–527. 2022.
|
|
23
|
Ward MP, Saadeh FA, O'Toole SA, O'Leary
JJ, Gleeson N and Norris LA: Procoagulant activity in high grade
serous ovarian cancer patients following neoadjuvant
chemotherapy-the role of the activated protein C pathway. Thromb
Res. 200:91–98. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Baddeley E, Pease NJ, Nelson A, Sulma J,
Crabtree A and Noble SIR: PO-04 The impact of a patient information
video on patient awareness and understanding of chemotherapy
induced cancer associated thrombosis. Thromb Res. 200(S19)2021.
|
|
25
|
Horsted F, West J and Grainge MJ: Risk of
venous thromboembolism in patients with cancer: A systematic review
and meta-analysis. PLoS Med. 9(e1001275)2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Haddad TC and Greeno EW:
Chemotherapy-induced thrombosis. Thromb Res. 118:555–568.
2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Alikhan R, Gomez K, Maraveyas A, Noble S,
Young A and Thomas M: British Society for Haematology:
Cancer-associated venous thrombosis in adults (second edition): A
British society for haematology guideline. Br J Haematol: Apr 25,
2024 (Epub ahead of print).
|
|
28
|
Sweetland S, Green J, Liu B, de González
AB, Canonico M, Reeves G and Beral V: Million Women Study
collaborators. Duration and magnitude of the postoperative risk of
venous thromboembolism in middle aged women: Prospective cohort
study. BMJ. 339(b4583)2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Heit JA, Cohen AT and Anderson FA:
Estimated annual number of incident and recurrent, non-fatal and
fatal venous thromboembolism (VTE) events in the US. Blood.
106(910)2005.
|
|
30
|
Jain A, Amira M, Manoharan S, Mahmood S
and Yip D: Role of direct oral anticoagulants in gastrointestinal
cancer associated thrombosis ‘practical issues in clinical
practice’-narrative review. Ann Palliat Med. 10:10053–10061.
2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kucher N and Goldhaber SZ: Cardiac
biomarkers for risc stratification of patients with acute pulmonary
embolism. Circulation. 108:2191–2194. 2003.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Vuilleumier N, Righini M, Perrier A,
Rosset A, Turck N, Sanchez JC, Bounameaux H, Le Gal G, Mensi N and
Hochstrasser D: Correlation between cardiac biomarkers and right
ventricular enlargement on chest CT in non massive pulmonary
embolism. Thromb Res. 121:617–624. 2008.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Giannitsis E, Müller-Bardorff M, Kurowski
V, Weidtmann B, Wiegand U, Kampmann M and Katus HA: Independent
prognostic value of cardiac troponin T in patients with confirmed
pulmonary embolism. Circulation. 102:211–217. 2000.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kontantinides S, Geibel A, Olschewski M,
Kasper W, Hruska N, Jäckle S and Binder L: Importance of cardiac
troponins I and T in risk stratification of patients with acute
pulmonary embolism. Circulation. 106:1263–1268. 2002.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mehta NJ, Jani K and Khan IA: Clinical
usefulness and prognostic value of elevated cardiac troponin I
levels in acute pulmonary embolism. Am Heart J. 145:821–825.
2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Meyer T, Binder L, Hruska N, Luthe H and
Buchwald AB: Cardiac troponin I elevation in acute pulmonary
embolism is associated with right ventricular dysfunction. J Am
Coll Cardiol. 36:1632–1636. 2000.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kucher N, Printzen G and Goldhaber SZ:
Prognostic role of brain natriuretic peptide in acute pulmonary
embolism. Circulation. 107:2545–2547. 2003.PubMed/NCBI View Article : Google Scholar
|
|
38
|
ten Wolde M, Tulevski II, Mulder JW, Söhne
M, Boomsma F, Mulder BJ and Büller HR: Brain natriuretic peptide as
a predictor of adverse outcome in patients with pulmonary embolism.
Circulation. 107:2082–2084. 2003.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sohne M, ten Wolde M and Büller HR:
Biomarkers in pulmonary embolism. Curr Opin Cardiol. 19:558–562.
2004.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Pruszczyk P, Kostrubiec M, Bochowicz A,
Styczyński G, Szulc M, Kurzyna M, Fijalkowska A, Kuch-Wocial A,
Chlewicka I and Torbicki A: N-terminal pro-brain natriuretic
peptide in patients with acute pulmonary embolism. Eur Respir J.
22:649–653. 2003.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Quiroz R, Kucher N, Schoepf UJ,
Kipfmueller F, Solomon SD, Costello P and Goldhaber SZ: Right
ventricular enlargement on chest computed tomography: Prognostic
role in acute pulmonary embolism. Circulation. 109:2401–2404.
2004.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Sanchez O, Trinquart L, Colombet I,
Durieux P, Huisman MV, Chatellier G and Meyer G: Prognostic value
of right ventricular dysfunction in patients with haemodynamically
stable pulmonary embolism: A systematic review. Eur Heart J.
29:1569–1577. 2008.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Klok FA, Mos ICM and Huisman MV:
Brain-type natriuretic peptide levels in the prediction of adverse
outcome in patients with pulmonary embolism: A systematic review
and meta-analysis. Am J Respir Crit Care Med. 178:425–430.
2008.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Horlander KT and Leeper KV: Troponin
levels as a guide to treatment of pulmonary embolism. Curr Opin
Pulm Med. 9:374–377. 2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Henzler T, Roeger S, Meyer M, Schoepf UJ,
Nance JW Jr, Haghi D, Kaminski WE, Neumaier M, Schoenberg SO and
Fink C: Pulmonary embolism: CT signs and cardiac biomarkers for
predicting right ventricular dysfunction. Eur Respir J. 39:919–926.
2012.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Hama N, Itoh H, Shirakami G, Nakagawa O,
Suga S, Ogawa Y, Masuda I, Nakanishi K, Yoshimasa T, Hashimoto Y,
et al: Rapid ventricular induction of brain natriuretic peptide
gene expression in experimental acute myocardial infarction.
Circulation. 92:1558–1564. 1995.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hall C: Essential biochemistry and
physiology of (NT-pro)BNP. Eur J Heart Fail. 6:257–260.
2004.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Joolharzadeh P, Rodriguez M, Zaghlol R,
Pedersen LN, Jimenez J, Bergom C and Mitchell JD: Recent advances
in serum biomarkers for risk stratification and patient management
in cardio-oncology. Curr Cardiol Rep. 25:133–146. 2023.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Frémont B, Pacouret G, Jacobi D, Puglisi
R, Charbonnier B and de Labriolle A: Prognostic value of
echocardiographic right/left ventricular end-diastolic diameter
ratio in patients with acute pulmonary embolism: Results from a
monocenter registry of 1,416 patients. Chest. 133:358–362.
2008.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Grifoni S, Olivotto I, Cecchini P,
Pieralli F, Camaiti A, Santoro G, Conti A, Agnelli G and Berni G:
Short-term clinical outcome of patients with acute pulmonary
embolism, normal blood pressure, and echocardiographic right
ventricular dysfunction. Circulation. 101:2817–2822.
2000.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Goldhaber SZ: Pulmonary embolism. N Engl J
Med. 339:93–104. 1998.PubMed/NCBI View Article : Google Scholar
|
|
52
|
de Lemos JA, McGuire DK and Drazner MH:
B-type natriuretic peptide in cardiovascular disease. Lancet.
362:316–322. 2003.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Tulevski II, Hirsch A, Sanson BJ, Romkes
H, van der Wall EE, van Veldhuisen DJ, Büller HR and Mulder BJ:
Increased brain natriuretic peptide as a marker for right
ventricular dysfunction in acute pulmonary embolism. Thromb
Haemost. 86:1193–1196. 2001.PubMed/NCBI
|
|
54
|
Kucher N, Printzen G, Doernhoefer T,
Windecker S, Meier B and Hess OM: Low pro-brain natriuretic peptide
levels predict benign clinical outcome in acute pulmonary embolism.
Circulation. 107:1576–1578. 2003.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Nagaya N, Nishikimi T, Okano Y, Uematsu M,
Satoh T, Kyotani S, Kuribayashi S, Hamada S, Kakishita M, Nakanishi
N, et al: Plasma brain natriuretic peptide levels increase in
proportion to the extent of right ventricular dysfunction in
pulmonary hypertension. J Am Coll Cardiol. 31:202–208.
1998.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Nagaya N, Nishikimi T, Uematsu M, Satoh T,
Kyotani S, Sakamaki F, Kakishita M, Fukushima K, Okano Y, Nakanishi
N, et al: Plasma brain natriuretic peptide as a prognostic
indicator in patients with primary pulmonary hypertension.
Circulation. 102:865–870. 2000.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Bando M, Ishii Y, Sugiyama Y and Kitamura
S: Elevated plasma brain natriuretic peptide levels in chronic
respiratory failure with cor pulmonale. Respir Med. 93:507–514.
1999.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Tulevski II, Groenink M, van Der Wall EE,
van Veldhuisen DJ, Boomsma F, Stoker J, Hirsch A, Lemkes JS and
Mulder BJ: Increased brain and atrial natriuretic peptides in
patients with chronic right ventricular pressure overload:
Correlation between plasma neurohormones and right ventricular
dysfunction. Heart. 86:27–30. 2001.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Thygesen K, Mair J, Mueller C, Huber K,
Weber M, Plebani M, Hasin Y, Biasucci LM, Giannitsis E, Lindahl B,
et al: Recommendations for the use of natriuretic peptides in acute
cardiac care: A position statement from the study group on
biomarkers in cardiology of the ESC working group on acute cardiac
care. Eur Heart J. 33:2001–2006. 2012.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Binder L, Pieske B, Olchewski M, Geibel A,
Klostermann B, Reiner C and Konstantinides S: N-terminal pro-brain
natriuretic peptide or troponin testing followed by
echocardiography for risk stratification of acute pulmonary
embolism. Circulation. 112:1573–1579. 2005.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Wodzig KW, Pelsers MM, van der Vusse GJ,
Roos W and Glatz JF: One-step enzyme-linked immunosorbent assay
(ELISA) for plasma fatty acid-binding protein. Ann Clin Biochem.
34:263–268. 1997.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Cavallazzi R, Nair A, Vasu T and Marik PE:
Natriuretic peptides in acute pulmonary embolism: A systematic
review. Intensive Care Med. 34:2247–2256. 2008.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Coutance G, Cauderlier E, Ehtisham J and
Hamon M and Hamon M: The prognostic value of markers of right
ventricular dysfunction in pulmonary embolism: A meta-analysis.
Crit Care. 15(R103)2011.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Lega JC, Lacasse Y, Lakhal L and
Provencher S: Natriuretic peptides and troponins in pulmonary
embolism: A meta-analysis. Thorax. 64:869–875. 2009.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Lankeit M, Jiménez D, Kostrubiec M, Dellas
C, Kuhnert K, Hasenfuß G, Pruszczyk P and Konstantinides S:
Validation of N-terminal pro-brain natriuretic peptide cut-off
values for risk stratification of pulmonary embolism. Eur Respir J.
43:1669–1677. 2014.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Agterof MJ, Schutgens RE, Moumli N,
Eijkemans MJ, van der Griend R, Tromp EA and Biesma DH: A
prognostic model for short term adverse events in normotensive
patients with pulmonary embolism. Am J Hematol. 86:646–649.
2011.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Klok FA, Van Der Bijl N, Eikenboom HC, Van
Rooden CJ, De Roos A, Kroft LJ and Huisman MV: Comparison of CT
assessed right ventricular size and cardiac biomarkers for
predicting short-term clinical outcome in normotensive patients
suspected for having acute pulmonary embolism. J Thromb Haemost.
8:853–856. 2010.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Kostrubiec M, Pruszczyk P, Bochowicz A,
Pacho R, Szulc M, Kaczynska A, Styczynski G, Kuch-Wocial A,
Abramczyk P, Bartoszewicz Z, et al: Biomarker-based risk assessment
model in acute pulmonary embolism. Eur Heart J. 26:2266–2272.
2005.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Lankeit M, Friesen D, Aschoff J, Dellas C,
Hasenfuss G, Katus H, Konstantinides S and Giannitsis E: Highly
sensitive troponin T assay in normotensive patients with acute
pulmonary embolism. Eur Heart J. 31:1836–1844. 2010.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Dellas C, Puls M, Lankeit M, Schäfer K,
Cuny M, Berner M, Hasenfuss G and Konstantinides S: Elevated
heart-type fatty acid-binding protein levels on admission predict
an adverse outcome in normotensive patients with acute pulmonary
embolism. J Am Coll Cardiol. 55:2250–2257. 2010.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Ozsu S, Karaman K, Mentese A, Ozsu A,
Karahan SC, Durmus I, Oztuna F, Kosucu P, Bulbul Y and Ozlu T:
Combined risk stratification with computerized tomography
/echocardiography and biomarkers in patients with normotensive
pulmonary embolism. Thromb Res. 126:486–492. 2010.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Steering Committee: Single-bolus
tenecteplase plus heparin compared with heparin alone for
normotensive patients with acute pulmonary embolism who have
evidence of right ventricular dysfunction and myocardial injury:
Rationale and design of the pulmonary embolism thrombolysis
(PEITHO) trial. Am Heart J. 163:33–38.e1. 2012.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Meyer G, Vicaut E, Danays T, Agnelli G,
Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B,
Couturaud F, et al: Fibrinolysis for patients with acute
intermediate-risk pulmonary embolism. N Engl J Med. 370:1402–1411.
2014.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Pruszczyk P, Bochowicz A, Torbicki A,
Szulc M, Kurzyna M, Fijałkowska A and Kuch-Wocial A: Cardiac
troponin T monitoring identifies high-risk group of normotensive
patients with acute pulmonary embolism. Chest. 123:1947–1952.
2003.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Vuilleumier N, Le Gal G, Verschuren F,
Perriers A, Bounameaux H, Turck N, Sanchez JC, Mensi N, Perneger T,
Hochstrasser D and Righini M: Cardiac biomarkers for risk
stratification in non-massive pulmonary embolism: A multicenter
prospective study. J Thromb Haemost. 7:391–398. 2008.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Kucher N and Goldhaber SZ: Cardiac
biomarkers for risk stratification of patients with acute pulmonary
embolism. Circulation. 108:2191–2194. 2003.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Lee AYY, Julian JA, Levine MN, Weit JI,
Kearon C, Wells PS and Ginsberg JS: Clinical utility of a rapid
whole-blood D-dimer assay in patients with cancer who present with
suspected acute deep venous thrombosis. Am Intern Med. 131:417–423.
1999.PubMed/NCBI View Article : Google Scholar
|
|
78
|
ten Wolde M, Kraaijenhagen RA, Prins MH
and Buller HR: The clinical usefulness of D-dimer testing in cancer
patients with suspected deep venous thrombosis. Arch Intern Med.
162:1880–1884. 2002.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Di Nisio M, Sohne M, Kamphuisen PW and
Büller HR: D-dimer test in cancer patients with suspected acute
pulmonary embolism. J Thromb Haemost. 3:1239–1242. 2005.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Kelly J, Rudd A, Lewis RR and Hunt BJ:
Plasma D-dimers in the diagnosis of venous thromboembolism. Arch
Intern Med. 162:747–756. 2002.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Levine MN, Raskob G, Beyth RJ, Kearon C
and Schulman S: Hemorrhagic complication of anticoagulant
treatment. The seventh ACCP conference on antithrombotic and
thrombolytic therapy. Chest. 126 (3 Suppl):287S–310S.
2004.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Stein PD, Hull RD, Patel KC, Olson RE,
Ghali WA, Brant R, Biel RK, Bharadia V and Kalra NK: D-dimer for
the exclusion of acute venous thrombosis and pulmonary embolism: A
systematic review. Am Intern Med. 140:589–602. 2004.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Brown MD, Rowe BH, Reeves MJ, Bermingham
JM and Goldhaber SZ: The accuracy of the enzyme-linked
immunosorbent assay D-dimer test in the diagnosis of pulmonary
embolism: A meta-analysis. Ann Emerg Med. 40:133–144.
2002.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Wikan VE, Tøndel BG, Morelli VM, Brodin
EE, Brækkan SK and Hansen JB: Diagnostic blood biomarkers for acute
pulmonary embolism: A systematic review. Diagnostics (Basel).
13(2301)2023.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Silva BV, Calé R, Menezes MN, Jorge C,
Pinto FJ and Caldeira D: How to predict prognosis in patients with
acute pulmonary embolism? Recent advances. Kardiol Pol. 81:684–691.
2023.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Stein PD, Terrin ML, Hales CA, Palevsky
HI, Saltzman HA, Thompson BT and Weg JG: Clinical, laboratory,
roentgenographic, and electrocardiographic findings in patients
with acute pulmonary embolism and no pre-existing cardiac or
pulmonary disease. Chest. 100:598–603. 1991.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Chou T and Knilans TK: Electrocardiography
in clinical practice: Adult and pediatric; 4th edition.
Philadelphia: Saunders, pp167-170, 1996.
|
|
88
|
Konstantinides S: Pulmonary Embolism:
Impact of right ventricular dysfunction. Curr Opin Cardiol.
20:496–501. 2005.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Goldhaber SZ, Visani L and De Rosa M:
Acute pulmonary embolism: clinical outcomes in the international
cooperative pulmonary embolism registry (ICOPER). Lancet.
353:1386–1389. 1999.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Becattini C, Vedovati MC and Agnelli G:
Prognostic value of troponins in acute pulmonary embolism: A
meta-analysis. Circulation. 116:427–433. 2007.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Kreit JW: The impact of right ventricular
dysfunction on the prognosis and therapy of normotensive patients
with pulmonary embolism. Chest. 125:1539–1545. 2004.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Leacche M, Unic D, Goldhaber SZ, Rawn JD,
Aranki SF, Couper GS, Mihaljevic T, Rizzo RJ, Cohn LH, Aklog L and
Byrne JG: Modern surgical treatment of massive pulmonary embolism:
Results in 47 consecutive patients after rapid diagnosis and
aggressive surgical approach. J Thorac Cardiovasc Surg.
129:1018–1023. 2005.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Kasper W, Konstantinides S, Geibel A,
Tiede N, Krause T and Just H: Prognostic significance of right
ventricular afterload stress detected by echocardiography in
patients with clinically suspected pulmonary embolism. Heart.
77:346–349. 1997.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Ribeiro A, Lindmarker P, Juhlin-Dannfelt
A, Johnsson H and Jorfeldt L: Echocardiography Doppler in pulmonary
embolism: Right ventricular dysfunction as a predictor of mortality
rate. Am Heart J. 134:479–487. 1997.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Araoz PA, Gotway MB, Harrington JR,
Harmsen WS and Mandrekar JN: Pulmonary embolism: Prognostic CT
findings. Radiology. 242:889–897. 2007.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Ghaye B, Ghuysen A, Willems V, Lambermont
B, Gerard P, D'Orio V, Gevenois PA and Dondelinger RF: Severe
pulmonary embolism:Pulmonary artery clot load scores and
cardiovascular parameters as predictors of mortality. Radiology.
239:884–891. 2006.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Ghuysen A, Ghaye B, Willems V, Lambermont
B, Gerard P, Dondelinger RF and D'Orio V: Computed tomographic
pulmonary angiography and prognostic significance in patients with
acute pulmonary embolism. Thorax. 60:956–961. 2005.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Mansencal N, Joseph T, Vieillard-Baron A,
Langlois S, El Hajjam M, Qanadli SD, Lacombe P, Jardin F and
Dubourg O: Diagnosis of right ventricular dysfunction in acute
pulmonary embolism using helical computed tomography. Am J Cardiol.
95:1260–1263. 2005.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Schoepf UJ, Kucher N, Kipfmueller F,
Quiroz R, Costello P and Goldhaber SZ: Right ventricular
enlargement on chest computed tomography: A predictor of early
death in acute pulmonary embolism. Circulation. 110:3276–3280.
2004.PubMed/NCBI View Article : Google Scholar
|
|
100
|
van der Meer RW, Pattynama PM, van Strijen
MJ, van den Berg-Huijsmans AA, Hartmann IJ, Putter H, de Roos A and
Huisman MV: Right ventricular dysfunction and pulmonary obstruction
index at helical CT: Prediction of clinical outcome during 3-month
follow-up in patients with acute pulmonary embolism. Radiology.
235:798–803. 2005.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Contractor S, Maldjian PD, Sharma VK and
Gor DM: Role of helical CT in detecting right ventricular
dysfunction secondary to acute pulmonary embolism. J Comput Assist
Tomogr. 26:587–591. 2002.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Lim KE, Chan CY, Chu PH, Hsu YY and Hsu
WC: Right ventricular dysfunction secondary to acute massive
pulmonary embolism detected by helical computed tomography
pulmonary angiography. Clin Imaging. 29:16–21. 2005.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Mann DL, Zipes DP, Libby P and Bonow RO
(eds): Braunwaldʼs heart disease. A textbook of cardiovascular
medicine, single volume, 10th edition. Elsevier Saunders, 2015.
|
|
104
|
Oride T, Sawada K, Shimizu A, Kinose Y,
Takiuchi T, Kodama M, Hashimoto K, Kobayashi E, Nakatani E and
Kimura T: Clinical trial assessing the safety of edoxaban with
concomitant chemotherapy in patients with gynecological
cancer-associated thrombosis (EGCAT study). Thromb J.
21(57)2023.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Konstantinides S and Goldhaber SZ:
Pulmonary embolism: Risk assessment and management. Eur Heart J.
33:3014–3022. 2012.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Guyatt GH, Akl EA, Crowther M, Gutterman
DD and Schuünemann HJ: American College of Chest Physicians
Antithrombotic Therapy and Prevention of Thrombosis Panel.
Executive summary: Antithrombotic therapy and prevention of
thrombosis, 9th ed: American college of chest physicians
evidence-based clinical practice guidelines. Chest. 141 (2
Suppl):7S–47S. 2012.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Limbrey R and Howard L: Developments in
the management and treatment of pulmonary embolism. Eur Respir Rev.
24:484–497. 2015.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Lewis JE and Pilcher DV: The management of
pulmonary embolism. Anaesth Intensive Care Med. 18:126–132.
2017.
|
|
109
|
Muriel A, Jiménez D, Aujesky D, Bertoletti
L, Decousus H, Laporte S, Mismetti P, Muñoz FJ, Yusen R and Monreal
M: RIETE Investigators. Survival effects of inferior vena cava
filter in patients with acute symptomatic venous thromboembolism
and a significant bleeding risk. J Am Coll Cardiol. 63:1675–1683.
2014.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Zamorano JL, Lancellotti P, Rodriguez
Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ,
Lip GYH, Lyon AR, et al: 2016 ESC position paper on cancer
treatments and cardiovascular toxicity developed under the auspices
of the ESC committee for practice guidelines: The task force for
cancer treatments and cardiovascular toxicity of the European
society of cardiology (ESC). Eur Heart J. 37:2768–2801.
2016.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Louzada ML, Carrier M, Lazo-Langner A, Dao
V, Kovacs MJ, Ramsay TO, Rodger MA, Zhang J, Lee AYY, Meyer G and
Wells PS: Development of a clinical prediction rule for risk
stratification of recurrent venous thromboembolism in patients with
cancer-associated venous thromboembolism. Circulation. 126:448–454.
2012.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Akl EA, Vasireddi SR, Gunukula S, Barba M,
Sperati F, Terrenato I, Muti P and Schünemann H: Anticoagulation
for the initial treatment of venous thromboembolism in patients
with cancer. Cochrane Database Syst Rev: CD006649, 2011.
|
|
113
|
Carrier M, Le Gal G, Cho R, Tierney S,
Rodger M and Lee AY: Dose escalation of low molecular weight
heparin to manage recurrent venous thromboembolic events despite
systemic anticoagulation in cancer patients. J Thromb Haemost.
7:760–765. 2009.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Kearon C, Akl EA, Ornelas J, Blaivas A,
Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, et
al: Antithrombotic therapy for VTE disease: CHEST guideline and
expert panel report. Chest. 149:315–352. 2016.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Mantha S and Ansell J: Indirect comparison
of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment
of acute venous thromboembolism. J Thromb Thrombolysis. 39:155–156.
2015.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Hokusai-VTE Investigators. Büller HR,
Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob
GE, Schellong SM, Schwocho L, et al: Edoxaban versus warfarin for
the treatment of symptomatic venous thromboembolism. N Engl J Med.
369:1406–1415. 2013.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Levine MN, Gu C, Liebman HA, Escalante CP,
Solymoss S, Deitchman D, Ramirez L and Julian J: A randomized phase
II trial of apixaban for the prevention of thromboembolism in
patients with metastatic cancer. J Thromb Haemost. 10:807–814.
2012.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Cohen AT, Spiro TE, Büller HR, Haskell L,
Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, et
al: Rivaroxaban for thromboprophylaxis in acutely ill medical
patients. N Engl J Med. 368:513–523. 2013.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Gussoni G, Frasson S, La Regina M, Di
Micco P and Monreal M: RIETE Investigators. Three-month mortality
rate and clinical predictors in patients with venous
thromboembolism and cancer. Findings from the RIETE registry.
Thromb Res. 131:24–30. 2013.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Lee AYY: Epidemiology and management of
venous thromboembolism in patients with cancer. Thromb Res.
110:167–172. 2003.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Kakkar AK: An expanding role for
antithrombotic therapy in cancer patients. Cancer Treat Rev. 29
(Suppl 2):S23–S26. 2003.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Sørensen HT, Mellemkjaer L, Olsen JH and
Baron JA: Prognosis of cancers associated with venous
thromboembolism. N Engl J Med. 343:1846–1850. 2000.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Buller HR, Agnelli G, Hull RD, Hyers TM,
Prins MH and Raskob GE: Antithrombotic therapy for venous
thromboembolic disease: The Seventh ACCP conference on
antithrombotic and thrombolytic therapy. Chest. 126 (3
Suppl):401S–428S. 2004.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Masini M, Toma M, Spallarossa P, Porto I
and Ameri P: Direct oral anticoagulants for cancer-associated
venous thromboembolism. Curr Oncol Rep. 25:979–987. 2023.PubMed/NCBI View Article : Google Scholar
|
